Skip to main content

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

TCRT holding history

Alaunos Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TCRT overviewAll 13F holders of TCRTFull Q2 2026 holdings

Shares (Q3 2024)
0
Sold out in Q3 2024
Value
$0
% of portfolio
0.0%
Quarters held
12
Since Q1 2021
Holdings of TCRT by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20240$00.0%−1,271−100.0%Sold outConverted for a 1-for-10 splitHolders
Q2 202412,709$8.88K<0.1%−284−2.2%ReducedHolders
Q1 202412,993$23.5K<0.1%+12,993NewHolders
Q3 20230$00.0%−90,379−100.0%Sold outHolders
Q2 202390,379$46.1K<0.1%−956−1.0%ReducedHolders
Q1 202391,335$57.5K<0.1%00.0%UnchangedHolders
Q4 202291,335$60.0K<0.1%00.0%UnchangedHolders
Q3 202291,335$157.0K<0.1%−14,007−13.3%ReducedHolders
Q2 2022105,342$130.0K<0.1%00.0%UnchangedHolders
Q1 2022105,342$69.0K<0.1%00.0%UnchangedHolders
Q4 2021105,342$115.0K<0.1%+1,216+1.2%AddedHolders
Q3 2021104,126$190.0K<0.1%−66,169−38.9%ReducedHolders
Q2 2021170,295$450.0K<0.1%−2,191−1.3%ReducedHolders
Q1 2021172,486$621.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.